Clinical Trial Update: A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 clinical study evaluating SHR-A1811 as a subcutaneous injection in patients with solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• SHR-A1811

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Solid Tumor | Phase 1 | Status: RECRUITING